BBR treatment likely ameliorated hepatic steatosis and fibrosis by protecting the liver from injury caused by lipoperoxide, because the mRNA expression of CYP2E1 and CYP4A10 was downregulated, and the mRNA expression of catalase was upregulated by BBR (Fig. 4E). This evidence concerns the gene CAT and fatty liver disease.